Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Drewa

Showing results (11-20 of 246) with videos related to

Pageof 25
Sort By:
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 7, 2007
[Treatment of liver failure using tissue engineering techniques]Marta Pokrywczyńska, Tomasz Drewa
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 6, 2014
Synthetic implants in hernia surgeryAleksander Lukasiewicz, Tomasz Drewa
Central European Journal of Urology|August 21, 2014
Adrenergic crisis due to pheochromocytoma - practical aspects. A short reviewKajetan Juszczak, Tomasz Drewa
European Urology|October 1, 2008
Re: Hervé Baumert, Mehrak Hekmati, Irene Dunia, et al. Laparoscopy in ureteral engineering: a feasibility study. Eur Urol 2008;54:1154-63Tomasz Drewa, Piotr Chlosta
Acta Biochimica Polonica|December 15, 2007
Leukemic stem cells: from metabolic pathways and signaling to a new concept of drug resistance targetingJan Styczynski, Tomasz Drewa
Central European Journal of Urology|August 24, 2016
The multiple biological action potential of melatonin - is melatonin, mitochondria and the ischemic/reperfusion injury relationship essential in the pathogenesis of obstructive nephropathy?Kajetan Juszczak, Tomasz Drewa
International Urology and Nephrology|February 24, 2007
Progenitor cells are responsible for formation primary epithelial cultures in the prostate epithelial modelTomasz Drewa, Jan Styczynski
Medical Hypotheses|August 19, 2008
Can conception of prostate cancer stem cells influence treatment dedicated to patients with disseminated disease?Tomasz Drewa, Jan Styczynski
European Urology|October 27, 2009
Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44Tomasz Drewa, Piotr Chlosta
Central European Journal of Urology|April 28, 2015
The cardiovascular and gastrointestinal adverse effects of cyclooxygenase inhibitors seems to be a major concern that restricts their use in the treatment of urinary bladder dysfunctionKajetan Juszczak, Tomasz Drewa
Pageof 25

Showing results (11-20 of 246) with videos related to

Sort By:
Pageof 25
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 7, 2007
[Treatment of liver failure using tissue engineering techniques]Marta Pokrywczyńska, Tomasz Drewa
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|March 6, 2014
Synthetic implants in hernia surgeryAleksander Lukasiewicz, Tomasz Drewa
Central European Journal of Urology|August 21, 2014
Adrenergic crisis due to pheochromocytoma - practical aspects. A short reviewKajetan Juszczak, Tomasz Drewa
European Urology|October 1, 2008
Re: Hervé Baumert, Mehrak Hekmati, Irene Dunia, et al. Laparoscopy in ureteral engineering: a feasibility study. Eur Urol 2008;54:1154-63Tomasz Drewa, Piotr Chlosta
Acta Biochimica Polonica|December 15, 2007
Leukemic stem cells: from metabolic pathways and signaling to a new concept of drug resistance targetingJan Styczynski, Tomasz Drewa
Central European Journal of Urology|August 24, 2016
The multiple biological action potential of melatonin - is melatonin, mitochondria and the ischemic/reperfusion injury relationship essential in the pathogenesis of obstructive nephropathy?Kajetan Juszczak, Tomasz Drewa
International Urology and Nephrology|February 24, 2007
Progenitor cells are responsible for formation primary epithelial cultures in the prostate epithelial modelTomasz Drewa, Jan Styczynski
Medical Hypotheses|August 19, 2008
Can conception of prostate cancer stem cells influence treatment dedicated to patients with disseminated disease?Tomasz Drewa, Jan Styczynski
European Urology|October 27, 2009
Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44Tomasz Drewa, Piotr Chlosta
Central European Journal of Urology|April 28, 2015
The cardiovascular and gastrointestinal adverse effects of cyclooxygenase inhibitors seems to be a major concern that restricts their use in the treatment of urinary bladder dysfunctionKajetan Juszczak, Tomasz Drewa
Pageof 25